Select your localized edition:

Close ×

More Ways to Connect

Discover one of our 28 local entrepreneurial communities »

Be the first to know as we launch in new countries and markets around the globe.

Interested in bringing MIT Technology Review to your local market?

MIT Technology ReviewMIT Technology Review - logo

 

Unsupported browser: Your browser does not meet modern web standards. See how it scores »

Be the problem tuberculosis, pneumonia, or simply children’s ear infections, antibiotic-resistant strains of bacteria responsible for such diseases continue to proliferate. Challenged by this public-health dilemma, scientists are searching for new ways to combat resilient bugs. Recognizing that one possible approach is to block their movement, cellular microbiologists are now monitoring bacterial pathways within host cells with a surprisingly familiar aid-video cameras.

In work as a research fellow at the MIT-affiliated Whitehead Institute for Biomedical Research, Julie A. Theriot has focused on the movement of two food-borne bacteria-Shigella, which causes dysentery, and Listeria, which triggers meningitis and stillbirths. She has found that after entering a host cell, these bacteria divide several times, then form “comet tails” that transport them directly among cells. This photograph shows the kidney cell of a kangaroo rat about four hours after it was injected with Listeria. Videos confirmed that proteins from both the bacteria’s surface and the host cell cooperated in drawing thousands of filaments (shown as green) to the bacteria (red) and in forming the tails. The elongating tails nudge the pathogens into adjacent cells, spreading the infection.

In work with other microbiologists, Theriot, who has recently moved to Stanford University, is determining which genes produce the bacterial proteins and also isolating the host-cell proteins involved. These steps could help in figuring out how to stop comet tails from forming and bacteria from moving from one cell to another. That, in turn, might lead to a more effective disease-fighting strategy than continually updating the antibiotics now used against bacteria such as Shigella.

0 comments about this story. Start the discussion »

Tagged: Biomedicine

Reprints and Permissions | Send feedback to the editor

From the Archives

Close

Introducing MIT Technology Review Insider.

Already a Magazine subscriber?

You're automatically an Insider. It's easy to activate or upgrade your account.

Activate Your Account

Become an Insider

It's the new way to subscribe. Get even more of the tech news, research, and discoveries you crave.

Sign Up

Learn More

Find out why MIT Technology Review Insider is for you and explore your options.

Show Me